Organisation paid for research Program year 2022 Source: CMS Open Payments

Bensch Research Associates

Neither a doctor nor a teaching hospital

Research payments

$110,165

13 payments

Through program year 2022, Bensch Research Associates is reported as receiving $110,165 in research payments, across 13 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2022	Research	$12,170	1
2021	Research	$39,159	1
2020	Research	$14,510	2
2019	Research	$44,326	9

Breakdown

Who paid Research payments · program years 2019–2022

Novartis Pharmaceuticals Corporation $83,652 7 payments
Sanofi US Services Inc. $26,512 6 payments

Studies the money was for Research payments · program years 2019–2022

A 12-Week, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Study to Assess the Efficacy and Safety of Csj117, When Added to Existing Asthma Therapy in Patients ? 18 Years of Age With Severe Uncontrolled Asthma. $64,750 3 payments
A Randomized, Double-blind, Placebo-controlled, Parallel-group, 12-week Proof-of-Concept (PoC) Study to Assess the Efficacy, Safety, and Tolerability of SAR440340 and the Coadministration of SAR440340 $26,512 6 payments
A 52 Week Multicenter Randomized Double Blind Placebocontrolled Study to Assess the Efficacy and Safety of Qaw039 When Added to Existing Asthma Therapy in Patients With Uncontrolled Severe Asthma $11,948 1 payment
A 12 Week Multicenter Randomized Double Blind Placebo Controlled Study to Assess the Efficacy and Safety of Qaw039 When Added to Standard of Care Asthma Therapy in Patients With Uncontrolled Asthma $5,595 2 payments
A Multi Center Randomized 52 Weeks Treatment Double Blind Triple Dummy Study to Assess the Efficacy and Safety of Qmf149 Compared With Mometasone Furoate and Salmeterol Fluticasone $1,360 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.